US IVD Market Future Discussed in New Report Recently Published at MarketPublishers.som

Submitted by admin on Fri, 01/13/2012 - 6:00pm

New research report “The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018” prepared by Venture Planning Group has been recently published by Market Publishers Ltd.

London, UK (PRWEB) January 13, 2012

How will the future reimbursement changes affect individual market segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export? How will the future technological advances affect the major market segments? Which companies will enter the market and which will not survive? The answers to all these and other key strategic questions can be found in the research report.

New research report “The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018” prepared by Venture Planning Group has been recently published by Market Publishers Ltd.

Report Details:

Title: The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018

Published: January, 2012

Pages: 135

Price: US$ 4,850

http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/us_in_vitro_diagnostics_market_outlook_strategic_implications_of_emerging_reimbursement_technological_n_market_trends_through_2018.html

The report delves into in-depth analysis of the U.S. in vitro diagnostics market’s future. It evaluates emerging markets and technologies presenting unexpected threats or offering opportunities; features major regulatory, economic, demographic and social trends; as well as offers five- and ten-year test volume and sales forecasts for key testing locations and laboratory disciplines.

Market segments covered in the report include: clinical chemistry and immunodiagnostics, microbiology and serology, hematology and flow cytometry, blood banking, histology and cytology, coagulation, urinalysis.

Technologies covered include: molecular diagnostics, monoclonal antibodies, solid phase chemistry, biosensors and biochips, automation and robotics, IT.

Report Contents:

1. Executive Summary

2. Conclusions and Recommendations

3. Business Environment

a. Health Care Expenditures

b. Cost-Consciousness

c. Reimbursement

d. Industry Consolidation

e. Hospitals

f. Admissions

g. Length of Stay

h. Industry Diversification

i. Physician Demographics

j. Aging Population

    More Chronic Illnesses

    Higher Incidence of Disease

    Greater Susceptibility to Iatrogenesis

    More Cases with Multiple Illnesses

4. Outlook for the In Vitro Diagnostics Market

a. Government Regulations

b. FDA Reform

c. Hospitals

d. Commercial Laboratories

e. Physician Offices

f. Point-of-Care Testing

g. Personal Testing

h. Other Testing Locations

5. Strategic Implications

a. Testing Patterns

    Test Utilization

    Pre-Admission Testing

    Inpatient Testing

    Outpatient Testing

6. Market Segments

a. Clinical Chemistry and Immunodiagnostics

    Introduction

    Future Situation

b. Microbiology and Serology

    Introduction

    Future Situation

c. Hematology and Flow Cytometry

    Introduction

    Future Situation

d. Blood Banking

    Introduction

    Future Situation

e. Histology and Cytology

    Introduction

    Future Situation

f. Coagulation

    Introduction

    Future Situation

g. Urinalysis

    Introduction

    Future Situation

7. Technologies

a. Molecular Diagnostics

    Introduction

    Future Situation

b. Monoclonal Antibodies

    Introduction

    Future Situation

c. Solid Phase Chemistry

    Introduction

    Future Situation

d. Biosensors and Biochips

    Introduction

    Future Situation

e. Automation and Robotics

    Introduction

    Future Situation

f. IT

    Introduction

    Future Situation

8. The New Marketplace

a. Purchasing Influences

b. Marketing Strategies

c. Joint Venture, Merger, and Licensing Activity

d. Import-Export

e. Potential Market Entrants

f. Who May Not Survive?

List of Tables

Executive Summary Table: Growth Areas in Clinical Laboratory Testing

Table-1: Estimated U.S. Health Care Expenditures By Expenditure Type

Table-2: Health Plan Enrollment Distribution

Table-3: Selected Hospital Statistics

Table-4: Total Population And Physician Demographics

Table-5: Test Volume By Location

Table-6: Test Distribution By Location

Table-7: Market Size By Location

Table-8: Typical Pre-Admission Tests

Table-9: Test Volume By Laboratory Discipline

Table-10: Market Size By Laboratory Discipline

More new market research reports by the publisher can be found at Venture Planning Group page.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/1/prweb9105276.htm